查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1722482

肝病治疗市场报告（按治疗类型、疾病类型（肝炎、自体免疫疾病、非酒精性脂肪肝、癌症、遗传性疾病等）、最终用户和地区划分）2025 年至 2033 年

Liver Disease Treatment Market Report by Treatment Type, Disease Type (Hepatitis, Autoimmune Diseases, Non-alcoholic Fatty Liver Disease, Cancer, Genetic Disorders, and Others), End User, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 150 Pages | 商品交期: 2-3个工作天内

价格

2024年全球肝病治疗市场规模达251亿美元。展望未来， IMARC Group预计到2033年市场规模将达到404亿美元，2025-2033年期间的成长率（CAGR）为5.44%。全球老年人口不断成长，容易患上肝病等多种慢性疾病，刺激了市场的发展。

肝臟是人体的重要器官，具有储存维生素和营养物质、清除血液中的有害物质、维持体内化学物质的适当平衡等重要功能。癌症、肝炎、自体免疫疾病和遗传性疾病是一些常见的肝臟疾病。这些疾病通常由感染、遗传、肥胖、糖尿病和免疫系统异常引起。一些广泛使用的肝病治疗技术包括疫苗、化疗、抗病毒药物、免疫球蛋白、皮质类固醇和免疫抑制剂。肝病治疗有助于胆固醇和荷尔蒙的排泄，增加胆汁的产生和酵素的活化。

肝病治疗市场趋势：

全球老年人口的不断增长，导致老年人易患各种慢性疾病，包括肝病，这是推动市场成长的主要因素之一。不断变化的饮食模式和久坐的生活方式正在推动市场成长。此外，由于高胆固醇、肥胖、高血压和糖尿病导致的脂肪肝盛行率不断上升，也有利于市场的成长。此外，生物人工肝的发展等各种技术进步正在为市场成长提供动力。它利用再生肝细胞来取代肝臟功能，广泛用于治疗急性肝衰竭患者。与此一致，抗病毒药物因其安全有效、有助于抑制乙肝病毒、并有助于降低肝硬化和肝细胞癌的风险而迅速被采用，对市场成长产生了积极影响。除此之外，研发活动的增加、医疗保健产业的显着成长以及政府为促进公共健康而实施的各种措施都为市场创造了积极的前景。

本报告回答的关键问题

  • 2024年全球肝病治疗市场规模？ 2025-2033年全球肝病治疗市场的预期成长率是多少？
  • 推动全球肝病治疗市场的关键因素有哪些？
  • COVID-19 对全球肝病治疗市场有何影响？
  • 根据治疗类型，全球肝病治疗市场如何分布？
  • 根据疾病类型，全球肝病治疗市场是如何分布的？
  • 根据最终用户，全球肝病治疗市场是如何分布的？
  • 全球肝病治疗市场的主要区域有哪些？
  • 全球肝病治疗市场的主要参与者/公司有哪些？

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

  • 概述
  • 主要行业趋势

第五章：全球肝病治疗市场

  • 市场概览
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场区隔：依治疗类型

  • 抗病毒药物
  • 免疫抑制剂
  • 疫苗
  • 免疫球蛋白
  • 皮质类固醇
  • 标靶治疗
  • 化疗

第七章：市场区隔：依疾病类型

  • 肝炎
  • 自体免疫疾病
  • 非酒精性脂肪肝（NAFLD）
  • 癌症
  • 遗传性疾病
  • 其他的

第八章：市场区隔：按最终用户

  • 医院
  • 门诊手术中心
  • 其他的

第九章：市场细分：依地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场区隔：依国家

第十章：SWOT分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第十三章：价格分析

第 14 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Abbott Laboratories
    • AbbVie Inc.
    • Astellas Pharma Inc.
    • Bristol-Myers Squibb Company
    • Eli Lilly and Company
    • Emergent BioSolutions Inc.
    • F. Hoffmann-La Roche AG
    • Gilead Sciences Inc.
    • GlaxoSmithKline plc
    • Merck & Co. Inc.
    • Novartis AG
    • Pfizer Inc.
    • Sanofi SA
    • Takeda Pharmaceutical Company Limited
    • Viatris Inc.
Product Code: SR112025A5023

The global liver disease treatment market size reached USD 25.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 40.4 Billion by 2033, exhibiting a growth rate (CAGR) of 5.44% during 2025-2033. The growing elderly population worldwide, which is prone to several chronic illnesses, including liver disease, is stimulating the market.

The liver is a vital organ of the human body that performs significant functions, such as storing vitamins and nutrients, removing harmful substances from the blood, and maintaining an adequate balance of chemicals in the body. Cancer, hepatitis, autoimmune diseases, and genetic disorders are some common liver diseases. These diseases are commonly caused by infections, genetics, obesity, diabetes, and immune system abnormalities. Some of the widely used therapeutic techniques for liver diseases include vaccines, chemotherapy, antiviral drugs, immunoglobulins, corticosteroids, and immunosuppressants. Liver disease treatment aids in the excretion of cholesterol and hormones, increases bile production and enzyme activation.

Liver Disease Treatment Market Trends:

The rising geriatric population, which is suspetible to various chronic ailments, including liver disease, across the globe is one of the prime factors driving the growth of the market. The changing dietary patterns and sedentary lifestyles are boosting the market growth. Additionally, the increasing prevalence of fatty liver disease due to high cholesterol, obesity, hypertension (high blood pressure), and diabetes is favoring the market growth. Moreover, various technological advancements, such as the development of the bioartificial liver, are providing an impetus to the market growth. It utilizes regenerated liver cells to replace liver functions and is widely used for acute liver failure patients. In line with this, the rapid adoption of antiviral drugs as they are safe and effective, assist in suppressing the hepatitis B virus, and help in reducing the risk of developing cirrhosis and hepatocellular carcinoma, is positively impacting the market growth. Apart from this, increasing research and development (R&D) activities, significant growth in the healthcare industry, and the implementation of various government initiatives to promote public health are creating a positive outlook for the market.

Key Market Segmentation:

Breakup by Treatment Type:

  • Antiviral Drugs
  • Immunosuppressants
  • Vaccines
  • Immunoglobulins
  • Corticosteroids
  • Targeted Therapy
  • Chemotherapy

Breakup by Disease Type:

  • Hepatitis
  • Autoimmune Diseases
  • Non-alcoholic Fatty Liver Disease (NAFLD)
  • Cancer
  • Genetic Disorders
  • Others

Breakup by End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, AbbVie Inc., Astellas Pharma Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Emergent BioSolutions Inc., F. Hoffmann-La Roche AG, Gilead Sciences Inc., GlaxoSmithKline plc, Merck & Co. Inc., Novartis AG, Pfizer Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited and Viatris Inc.

Key Questions Answered in This Report

  • 1.What was the size of the global liver disease treatment market in 2024?
  • 2.What is the expected growth rate of the global liver disease treatment market during 2025-2033?
  • 3.What are the key factors driving the global liver disease treatment market?
  • 4.What has been the impact of COVID-19 on the global liver disease treatment market?
  • 5.What is the breakup of the global liver disease treatment market based on the treatment type?
  • 6.What is the breakup of the global liver disease treatment market based on the disease type?
  • 7.What is the breakup of the global liver disease treatment market based on the end user?
  • 8.What are the key regions in the global liver disease treatment market?
  • 9.Who are the key players/companies in the global liver disease treatment market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Liver Disease Treatment Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Treatment Type

  • 6.1 Antiviral Drugs
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Immunosuppressants
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Vaccines
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Immunoglobulins
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Corticosteroids
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Targeted Therapy
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7 Chemotherapy
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast

7 Market Breakup by Disease Type

  • 7.1 Hepatitis
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Autoimmune Diseases
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Non-alcoholic Fatty Liver Disease (NAFLD)
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Cancer
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Genetic Disorders
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Ambulatory Surgical Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 AbbVie Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Astellas Pharma Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Bristol-Myers Squibb Company
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Eli Lilly and Company
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Emergent BioSolutions Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 F. Hoffmann-La Roche AG
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
    • 14.3.8 Gilead Sciences Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 GlaxoSmithKline plc
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Merck & Co. Inc.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Novartis AG
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Pfizer Inc.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis
    • 14.3.13 Sanofi S.A.
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio
      • 14.3.13.3 Financials
      • 14.3.13.4 SWOT Analysis
    • 14.3.14 Takeda Pharmaceutical Company Limited
      • 14.3.14.1 Company Overview
      • 14.3.14.2 Product Portfolio
      • 14.3.14.3 Financials
      • 14.3.14.4 SWOT Analysis
    • 14.3.15 Viatris Inc.
      • 14.3.15.1 Company Overview
      • 14.3.15.2 Product Portfolio
      • 14.3.15.3 Financials

List of Figures

  • Figure 1: Global: Liver Disease Treatment Market: Major Drivers and Challenges
  • Figure 2: Global: Liver Disease Treatment Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Liver Disease Treatment Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Liver Disease Treatment Market: Breakup by Treatment Type (in %), 2024
  • Figure 5: Global: Liver Disease Treatment Market: Breakup by Disease Type (in %), 2024
  • Figure 6: Global: Liver Disease Treatment Market: Breakup by End User (in %), 2024
  • Figure 7: Global: Liver Disease Treatment Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Liver Disease Treatment (Antiviral Drugs) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Liver Disease Treatment (Antiviral Drugs) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Liver Disease Treatment (Immunosuppressants) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Liver Disease Treatment (Immunosuppressants) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Liver Disease Treatment (Vaccines) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Liver Disease Treatment (Vaccines) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Liver Disease Treatment (Immunoglobulins) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Liver Disease Treatment (Immunoglobulins) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Liver Disease Treatment (Corticosteroids) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Liver Disease Treatment (Corticosteroids) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Liver Disease Treatment (Targeted Therapy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Liver Disease Treatment (Targeted Therapy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Liver Disease Treatment (Chemotherapy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Liver Disease Treatment (Chemotherapy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Liver Disease Treatment (Hepatitis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Liver Disease Treatment (Hepatitis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Liver Disease Treatment (Autoimmune Diseases) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Liver Disease Treatment (Autoimmune Diseases) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Liver Disease Treatment (Non-alcoholic Fatty Liver Disease (NAFLD)) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Liver Disease Treatment (Non-alcoholic Fatty Liver Disease (NAFLD)) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Liver Disease Treatment (Cancer) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Liver Disease Treatment (Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Global: Liver Disease Treatment (Genetic Disorders) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Global: Liver Disease Treatment (Genetic Disorders) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Global: Liver Disease Treatment (Other Disease Types) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Global: Liver Disease Treatment (Other Disease Types) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Global: Liver Disease Treatment (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Global: Liver Disease Treatment (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Global: Liver Disease Treatment (Ambulatory Surgical Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Global: Liver Disease Treatment (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Global: Liver Disease Treatment (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Global: Liver Disease Treatment (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: North America: Liver Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: North America: Liver Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: United States: Liver Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: United States: Liver Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Canada: Liver Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Canada: Liver Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Asia-Pacific: Liver Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Asia-Pacific: Liver Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: China: Liver Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: China: Liver Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Japan: Liver Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Japan: Liver Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: India: Liver Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: India: Liver Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: South Korea: Liver Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: South Korea: Liver Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Australia: Liver Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Australia: Liver Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Indonesia: Liver Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Indonesia: Liver Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Others: Liver Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Others: Liver Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Europe: Liver Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Europe: Liver Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Germany: Liver Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Germany: Liver Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: France: Liver Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: France: Liver Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: United Kingdom: Liver Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: United Kingdom: Liver Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Italy: Liver Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Italy: Liver Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Spain: Liver Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Spain: Liver Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Russia: Liver Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Russia: Liver Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Others: Liver Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Others: Liver Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 78: Latin America: Liver Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 79: Latin America: Liver Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 80: Brazil: Liver Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 81: Brazil: Liver Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 82: Mexico: Liver Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 83: Mexico: Liver Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 84: Others: Liver Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 85: Others: Liver Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 86: Middle East and Africa: Liver Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 87: Middle East and Africa: Liver Disease Treatment Market: Breakup by Country (in %), 2024
  • Figure 88: Middle East and Africa: Liver Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 89: Global: Liver Disease Treatment Industry: SWOT Analysis
  • Figure 90: Global: Liver Disease Treatment Industry: Value Chain Analysis
  • Figure 91: Global: Liver Disease Treatment Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Liver Disease Treatment Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Liver Disease Treatment Market Forecast: Breakup by Treatment Type (in Million USD), 2025-2033
  • Table 3: Global: Liver Disease Treatment Market Forecast: Breakup by Disease Type (in Million USD), 2025-2033
  • Table 4: Global: Liver Disease Treatment Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 5: Global: Liver Disease Treatment Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Liver Disease Treatment Market: Competitive Structure
  • Table 7: Global: Liver Disease Treatment Market: Key Players